Search
GWAS ID | Year | Trait | Consortium | Sample size | Number of SNPs |
---|---|---|---|---|---|
finn-b-F5_CANNABIS | 2021 | Mental and behavioural disorders due to cannabinoids | NA | — | 16,380,457 |
finn-b-F5_HALLUCIN | 2021 | Mental and behavioural disorders due to hallucinogens | NA | — | 16,380,434 |
finn-b-F5_OTHERSUB | 2021 | Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psycoactive substances | NA | — | 16,380,438 |
finn-b-F5_OPIOIDS | 2021 | Mental and behavioural disorders due to opioids | NA | — | 16,380,458 |
finn-b-F5_SUBSTANCE | 2021 | Mental and behavioural disorders due to psychoctive substance use | NA | — | 16,380,466 |
Data overview
The GWAS summary datasets are currently organised into the following 18 batches: